Resources from the same session
119O - Long-term efficacy and patterns of response of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study
Presenter: Martin Wermke
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2
Resources:
Webcast
48O - Safety and Efficacy of Combined Treatment with Tumor Infiltrating Lymphocytes (TILs) and Oncolytic Adenovirus TILT-123 for Patients with Metastatic Melanoma - Results from a Phase I Trial
Presenter: Tine Monberg
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
49O - Clinical Experience of Tabelecleucel in Epstein-Barr Virus-Positive Post-transplant Lymphoproliferative Disease (EBV+ PTLD) Involving the Central Nervous System
Presenter: John Patton
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Invited Discussant 48O and 49O
Presenter: George Coukos
Session: Proffered Paper session 2
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2
Resources:
Webcast